Hestia Insight (Hestia Insight) Change In Receivables : $-0.01 Mil (TTM As of Feb. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Hestia Insight Change In Receivables?

Hestia Insight's change in receivables for the quarter that ended in Feb. 2024 was $-0.01 Mil. It means Hestia Insight's Accounts Receivable increased by $0.01 Mil from Nov. 2023 to Feb. 2024 .

Hestia Insight's change in receivables for the fiscal year that ended in Nov. 2023 was $0.00 Mil. It means Hestia Insight's Accounts Receivable stayed the same from Nov. 2022 to Nov. 2023 .

Hestia Insight's Accounts Receivable for the quarter that ended in Feb. 2024 was $0.01 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Hestia Insight's Days Sales Outstanding for the three months ended in Feb. 2024 was 19.21.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Hestia Insight's liquidation value for the three months ended in Feb. 2024 was $0.13 Mil.

Hestia Insight Change In Receivables Historical Data

The historical data trend for Hestia Insight's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hestia Insight Change In Receivables Chart

Hestia Insight Annual Data

Trend

Nov22

Nov23

Change In Receivables

0.02

Hestia Insight Quarterly Data
	Feb22	Aug22	Nov22	Feb23	Aug23	Nov23	Feb24
Change In Receivables	Get a 7-Day Free Trial			-	-	-	-	-0.01

Hestia Insight Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01 Mil.

Hestia Insight (OTCPK:HSTA) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Hestia Insight's Days Sales Outstanding for the quarter that ended in Feb. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.008	/	0.038	*	91
=	19.21

2. In Ben Graham's calculation of liquidation value, Hestia Insight's accounts receivable are only considered to be worth 75% of book value:

Hestia Insight's liquidation value for the quarter that ended in Feb. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.18	-	0.061	+	0.75 * 0.008	+	0.5 * 0
=	0.13

Hestia Insight Change In Receivables Related Terms

Thank you for viewing the detailed overview of Hestia Insight's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Hestia Insight (Hestia Insight) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » Hestia Insight Inc (OTCPK:HSTA) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

400 S. 4th Street, Suite 500, Las Vegas, NV, USA, 89101

Website

http://www.hestiainsight.com

Hestia Insight Inc provides strategic consulting and capital market advisory services for micro, small and medium-sized companies in the healthcare, biotech and fintech sectors. It also provides access to seed capital and mezzanine funding for qualified emerging companies in these industries. The firm derives all of its revenue from consulting services.